Appointment

CafeDirect PLC Shares now trading on JP Jenkins

Retrieved on: 
Wednesday, April 10, 2024
Farmer, Appointment, Cafédirect, Coffee, Commercial, NEWS, Companies House, Security (finance)

10th April 2024 – Shares in Cafedirect PLC ( https://www.cafedirect.co.uk/ ) have been admitted to trade on JP Jenkins share dealing platform.

Key Points: 
  • 10th April 2024 – Shares in Cafedirect PLC ( https://www.cafedirect.co.uk/ ) have been admitted to trade on JP Jenkins share dealing platform.
  • Cafedirect plc is a British coffee company established in 1991 that is driven by a passion for fairness and sustainability.
  • JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
  • Veronika Oswald, Commercial Director of JP Jenkins said: “Congratulations to CafeDirect PLC for joining our securities trading venue.

Allarity Therapeutics Reports Full Year 2023 Financial Results and Provides a Business Update

Retrieved on: 
Friday, March 8, 2024
Eli Lilly, Therapy, Research, Enzyme, CDX, PARP, Drug development, DRP, ADP, Interim, Biomarker, Ovarian cancer, Administration, Patient, Oncology, G&A, Appointment, Cancer, Pharmaceutical industry

The Company's Interim Chief Executive Officer, Thomas Jensen, stated, “2023 was a year of remarkable achievements for Allarity Therapeutics as we made significant strides in advancing our DRP®-guided drug development.

Key Points: 
  • The Company's Interim Chief Executive Officer, Thomas Jensen, stated, “2023 was a year of remarkable achievements for Allarity Therapeutics as we made significant strides in advancing our DRP®-guided drug development.
  • Announced leadership changes and strategic advisory engagement:
    Appointment of co-founder Thomas H. Jensen as Interim Chief Executive Officer in December 2023.
  • With nearly two decades at Allarity Therapeutics, Jensen brings extensive experience and a deep understanding of the company’s DRP® to his new role.
  • Net Loss from Operations: Net Loss from Operations was $17.1 million for 2023, compared to $34 million for 2022.

Tintra Limited Shares now trading at JP Jenkins

Retrieved on: 
Monday, February 5, 2024
Appointment, 2nd Floor, Companies House, Artificial intelligence, Security (finance)

1st February 2024 – Shares in Tintra Limited (https://tintra.com/) have been admitted to trade on JP Jenkins share dealing platform.

Key Points: 
  • 1st February 2024 – Shares in Tintra Limited (https://tintra.com/) have been admitted to trade on JP Jenkins share dealing platform.
  • Tintra Limited has recently left LSE:AIM and joined JP Jenkins to support a wider investor audience.
  • JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
  • Data for the ordinary shares (ISIN: GB00BHXM9D70), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/company/tintra/)

Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments

Retrieved on: 
Thursday, January 25, 2024
Citadel, Portfolio manager, Neoplasm, Pharming, T. Rowe Price, Biology, Research, Health care, SAN, Medical school, Science, Princeton University, University, Pharmacology, Denison University, Cancer, Medication, Biomedical sciences, WEE1, Drug development, Therapy, Ovarian cancer, Doctor of Philosophy, Eventide, Appointment, Cowen Inc.

NEW YORK and SAN DIEGO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancer, today announced that Diana Hausman, M.D., a member of Zentalis’ Board of Directors, was appointed as Chief Medical Officer, and Kyle Rasbach, Ph.D., Pharm.D., was appointed as Chief Business Officer.

Key Points: 
  • “We are pleased to welcome Diana and Kyle to our management team.
  • During her career, she has contributed to the development of multiple cancer therapeutics, including small molecules, antibody drug conjugates, and immunotherapies.
  • In connection with her appointment as Chief Medical Officer, Dr. Hausman resigned from Zentalis’ Board of Directors.
  • Dr. Brownstein will remain with Zentalis as a consultant for a transitional period.

Newmont Strengthens Leadership Team with Appointment of Industry Leader Peter Wexler as Chief Legal Officer

Retrieved on: 
Wednesday, January 24, 2024
Mining, Minerals, Natural Resources, ASX, University, American University, NGT, Peter, Multimedia, Corporation, Financial Times, Law, APC by Schneider Electric, Risk, M&A, Gold, NEM, TSX, Schneider Electric, Risk management, Washington College of Law, Appointment, Engineering, Negotiation, Management

Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) today announced the appointment of Peter Wexler as Chief Legal Officer.

Key Points: 
  • Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) today announced the appointment of Peter Wexler as Chief Legal Officer.
  • Peter will join Newmont’s Executive Leadership Team and be responsible for leading the company’s legal, compliance and regulatory affairs globally.
  • View the full release here: https://www.businesswire.com/news/home/20240123636145/en/
    Newmont Strengthens Leadership Team with Appointment of Industry Leader Peter Wexler as Chief Legal Officer (Photo: Business Wire)
    Peter is an experienced legal and risk management leader with more than three decades of international knowledge in managing legal, risk, compliance, M&A, antitrust, litigation and corporate governance affairs within the industrial, technology, energy management, engineering, manufacturing, and construction sectors.
  • As Schneider Electric’s Chief Legal Officer, Peter managed the company’s legal, risk management and compliance matters across the globe and directed a team of over 300 professionals in 32 countries.

ADVANO Appoints J. Christopher York as Chief Executive Officer to Lead the Transition to an Application Oriented Enterprise Advancing Silicon-Carbon Composite Battery Materials

Retrieved on: 
Thursday, January 11, 2024
Lithium, EVS, Rail transport by country, Research, Growth, City, Partnership, Business development, Strategic planning, Appointment, SPP, EV, Commercialization, Inflation, Management

NEW ORLEANS, Jan. 11, 2024 /PRNewswire/ -- ADVANO, a silicon solutions provider, is accelerating the commercialization of its proprietary silicon anode "drop-in" technology, REALSi™. The transition to an application-oriented enterprise has been made possible with the new leadership of J. Christopher York and further advancements in ADVANO's silicon-carbon composite battery materials.

Key Points: 
  • The transition to an application-oriented enterprise has been made possible with the new leadership of J. Christopher York and further advancements in ADVANO's silicon-carbon composite battery materials.
  • ADVANO has engaged in significant product development efforts yielding a cost-effective, high-performance silicon-carbon composite material for energy storage.
  • Silicon is a critical material that will assume a leading role in the ongoing energy transition," said Christopher York.
  • Prior to joining ADVANO, Christopher held executive leadership positions for over two decades at distinguished companies, including NOVONIX and ELKEM.

Perpetua Resources Progressing Towards Next Phase

Retrieved on: 
Tuesday, January 2, 2024
SME, Nez Perce, Barrick Gold, Materials science, Mining, University, Gold, FEIS, Donlin Gold mine, Engineering, MBA, Perpetua and Felicity, Antimony, Society, CWA, Goldstrike mine, Metal, PPTA, Appointment, Reno 1868 FC, DOD, Project, TSX, USFS, Department of Defence, District court, NEPA

2023 Milestones Further Strengthen Project's Strategic Value to U.S. Critical Mineral Development

Key Points: 
  • 2023 Milestones Further Strengthen Project's Strategic Value to U.S. Critical Mineral Development
    BOISE, Idaho, Jan. 2, 2024 /PRNewswire/ - Perpetua Resources Corp. (Nasdaq: PPTA) (TSX: PPTA) ("Perpetua Resources" or "Perpetua" or the "Company") announced today that the Company is making progress as it continues to advance the Stibnite Gold Project ("Stibnite Gold Project" or "Project") through the regulatory process and toward a construction decision.
  • As Perpetua prepares for the next phase, the appointment of Andrew Cole to the Board of Directors enhances Perpetua's operational expertise and further strengthens its deep bench of experienced leaders.
  • Perpetua Resources is focused on advancing the permitting for the Stibnite Gold Project through the National Environmental Policy Act ("NEPA") process and construction readiness for the Project.
  • "Perpetua Resources accomplished several significant milestones in 2023 as we progress towards the next phase for the Stibnite Gold Project," said Laurel Sayer, President and CEO of Perpetua Resources.

Quantum Group shares go live on JP Jenkins’ share trading platform

Retrieved on: 
Wednesday, December 27, 2023
CFOS, Commercial, Cashback, Quantum group, FD, FX, IPO, Fintech, CREST, Appointment, Treasurer, Ecosystem, Belgrave Square, Companies House

London, 27th December: Quantum Financial Holdings Limited (“The Quantum Group”), a UK-based technology incubator which invests in the next generation of fintech and security companies, has been admitted onto JP Jenkins’ share trading platform.

Key Points: 
  • London, 27th December: Quantum Financial Holdings Limited (“The Quantum Group”), a UK-based technology incubator which invests in the next generation of fintech and security companies, has been admitted onto JP Jenkins’ share trading platform.
  • In what is a major milestone for the Company, Quantum Group’s shares will open at £22 per share with 15,024,000 shares in issue.
  • Quantum Group co-founder Floyd Woodrow MBE DCM said: “This is a major milestone for The Quantum Group as we join forces with JP Jenkins and admit our shares on their trading platform.
  • Shareholders wishing to trade Quantum Group shares can do so through their stockbroker.

Reconstruction Capital II Limited Company’s shares are now trading at JP Jenkins

Retrieved on: 
Thursday, December 21, 2023
ISIN, Cayman, RC2, Appointment, Windward and leeward, Security (finance)

21st December 2023 – Shares in Reconstruction Capital II Limited (“RC2” or the “Company”) (https://www.reconstructioncapital2.com/) have been admitted to trade on JP Jenkins share dealing platform.

Key Points: 
  • 21st December 2023 – Shares in Reconstruction Capital II Limited (“RC2” or the “Company”) (https://www.reconstructioncapital2.com/) have been admitted to trade on JP Jenkins share dealing platform.
  • JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
  • Trades will be conducted at a level that JP Jenkins is able to match a willing seller and a willing buyer.
  • The indicative pricing for the ordinary shares (ISIN: KYG741521028), as well as the transaction history, will be available on the JP Jenkins website at (https://jpjenkins.com/company/reconstruction-capital-ii-limited/)

Azerion announces new roles on its Supervisory Board

Retrieved on: 
Monday, November 20, 2023
Supervisory board, Appointment, Selection, Chair, Property management

Amsterdam, 20 November 2023 – Following its Extraordinary General Meeting held on 16 November 2023, Azerion is pleased to report that its Supervisory Board has appointed Wim de Pundert to the role of Chair, Florence von Erb to the role of Chair of the Selection, Appointment and Remuneration Committee and Zafer Karataş as a member of the Selection, Appointment and Remuneration Committee.

Key Points: 
  • Amsterdam, 20 November 2023 – Following its Extraordinary General Meeting held on 16 November 2023, Azerion is pleased to report that its Supervisory Board has appointed Wim de Pundert to the role of Chair, Florence von Erb to the role of Chair of the Selection, Appointment and Remuneration Committee and Zafer Karataş as a member of the Selection, Appointment and Remuneration Committee.
  • As part of the arrangements relating to these new appointments, Klaas Meertens has announced that he will step down from the Supervisory Board on 31 January 2024, after completing a two year term from his original appointment.
  • In line with its ongoing development, Azerion intends to continue introducing additional experience to its Supervisory Board with further updates expected in the coming months.
  • The roles on the Supervisory Board will be reviewed in light of any such additional appointments.